• AO/PI Double Staining Kit: Practical Guide for Cell Viabilit

  2026-06-13

  The AO/PI Double Staining Kit enables researchers to rapidly distinguish viable, apoptotic, and necrotic cells using dual fluorescent dyes in a single workflow. It is ideal for qualitative assessment of cell health in research settings but is not intended for clinical diagnostics or absolute quantification. Researchers should follow established protocols and quality control steps for optimal reproducibility.

• EZ Cap™ Cas9 mRNA (m1Ψ): Next-Gen Specificity and Assay Desi

  2026-06-12

  Explore how EZ Cap™ Cas9 mRNA (m1Ψ) with Cap1 structure advances CRISPR-Cas9 genome editing specificity and assay control. This in-depth analysis uniquely bridges mRNA engineering with workflow optimization and practical insights from recent research.

• Thymosin-β4 Promotes Angiogenesis in CLI via Notch/NF-κB Reg

  2026-06-12

  Lv et al. provide direct evidence that thymosin-β4 (Tβ4) drives angiogenesis in critical limb ischemia (CLI) by modulating the Notch and NF-κB pathways. Their integrative use of pathway inhibitors, including the IKK-1/IKK-2 inhibitor BMS-345541, clarifies the mechanistic landscape and suggests new avenues for therapeutic vascular regeneration in ischemic disease.

• Stiripentol: LDH Inhibition at the Crossroads of Metabolism

  2026-06-11

  This article examines how Stiripentol, a novel LDH inhibitor from APExBIO, enables translational researchers to dissect lactate metabolism and histone lactylation in neuroepileptic and tumor immunometabolic contexts. By integrating mechanistic insights from recent studies—including the emerging role of lactate-driven epigenetic modification in immune regulation—we offer strategic guidance for protocol design and highlight new frontiers for metabolic therapy research beyond standard product profiles.

• Optimizing Workflows with 10 mM dNTP Mixture: Experimental I

  2026-06-11

  The 10 mM dNTP (2'-deoxyribonucleoside-5'-triphosphate) Mixture streamlines complex DNA synthesis, PCR, and sequencing protocols by delivering equimolar, pH-stabilized nucleotides for maximal reaction efficiency. Recent advances in nanoparticle-mediated nucleic acid delivery underscore the critical role of high-purity molecular biology reagents, positioning APExBIO's dNTP mix as the gold standard for both established and emerging applications.

• A40926: Dalbavancin Precursor for Advanced Antibacterial Res

  2026-06-10

  A40926, the natural glycopeptide and dalbavancin precursor, offers unmatched versatility for Gram-positive and Neisseria gonorrhoeae inhibition assays. This article explores experimental workflows, nuanced troubleshooting, and the latest reference-backed innovations that set A40926 apart for antibiotic development and resistance studies.

• GS-441524 Prodrug: Translational Insights for Antiviral Inno

  2026-06-10

  Explore how GS-441524 prodrug advances antiviral research with unique conversion pathways and pharmacokinetic properties. This article provides in-depth analysis, bridging molecular mechanisms to practical decisions in anti-SARS-CoV-2 studies.

• GS-441524: Pharmacokinetic Innovation and Prodrug Conversion

  2026-06-09

  Explore how GS-441524, a potent nucleoside analog, advances antiviral research through novel prodrug strategies and cutting-edge pharmacokinetic insights. This article reveals unique mechanistic findings and practical assay guidance for GS-441524 prodrug workflows.

• VX-765 and VRT-043198: Transforming Caspase-1 Inhibition Res

  2026-06-09

  This thought-leadership article explores the mechanistic power and translational promise of VX-765, a potent and selective caspase-1 inhibitor, and its active metabolite VRT-043198. Integrating state-of-the-art evidence on pyroptosis, cytokine modulation, and emerging mitochondrial links, it offers strategic guidance for researchers navigating inflammation, immunometabolism, and cell death in disease models. The discussion bridges preclinical advances with actionable insights, highlights competitive differentiation, and projects a visionary outlook for the field.

• WSP-5: Illuminating Endogenous H2S in Disease Models

  2026-06-08

  Explore the scientific advantages of WSP-5, a turn-on fluorogenic sensor for hydrogen sulfide, in the advanced visualization of H2S dynamics across live-cell and disease-relevant models. Discover how its unique mechanism and rapid kinetics support research in cardiometabolic disease and beyond.

• High-Throughput BBB Permeability Prediction Using LLC-PK1-MD

  2026-06-08

  This study introduces a robust in vitro surrogate blood-brain barrier (BBB) model integrating LLC-PK1-MOCK/MDR1 cells and lysosomal trapping correction for high-throughput CNS drug screening. By closely replicating physiological BBB features and improving permeability predictions, this model addresses longstanding challenges in early-stage neurological drug development.

• Aligned Silk Fibroin–Ce6 Nanofiber Films for Antibacterial P

  2026-06-07

  This study presents an aligned silk fibroin nanofiber film conjugated with Chlorin e6 (Ce6), enabling rapid, photodynamically triggered antibacterial activity against S. aureus under NIR irradiation. The engineered scaffold not only eliminates biofilm-associated infection but also modulates macrophage polarization, offering a multifaceted approach to chronic wound healing where antibiotic resistance is a challenge.

• Redefining Reporter mRNA: Mechanisms and Strategy for Transl

  2026-06-06

  This article explores the mechanistic advances and strategic imperatives driving next-generation firefly luciferase mRNA tools—specifically 5-moUTP-modified, Cap 1-capped transcripts—in translational research. Emphasizing immune evasion, stability, and delivery innovation, we examine recent breakthroughs and deliver actionable protocol guidance for researchers pioneering bioluminescent assays, mRNA delivery, and immune monitoring.

• Cy5 NHS ester(Et): Technical Guide for Amino Group Labeling

  2026-06-05

  Cy5 NHS ester(Et) enables direct, water-soluble fluorescent labeling of primary amines in proteins, peptides, and related biomolecules for applications such as immunofluorescence staining and flow cytometry. This reagent is not suitable for ethanol-based workflows or for protocols requiring dye solutions to be stored long-term. Proper dissolution and immediate use are essential for optimal results.

• Broussonetia papyrifera Fruit Extract Disrupts Aβ-Oxidative

  2026-06-05

  This study demonstrates that the ethyl acetate fraction of Broussonetia papyrifera fruit (FBA) disrupts the pathological cycle between amyloid-beta toxicity and oxidative stress in C. elegans and cellular models of Alzheimer’s disease. The findings elucidate multiple neuroprotective mechanisms, offering pharmacological insight into the fruit’s traditional use for cognitive decline.

11165 records 1/745 page Next 12345 下5页 Last page